Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Riboflavin 5-phosphate
Drug ID BADD_D01934
Description A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues.
Indications and Usage Not Available
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB03247
KEGG ID Not Available
MeSH ID D005486
PubChem ID 710
TTD Drug ID D00IBG
NDC Product Code Not Available
UNII Not Available
Synonyms Flavin Mononucleotide | Mononucleotide, Flavin | Riboflavin 5'-Phosphate | 5'-Phosphate, Riboflavin | Riboflavin 5' Phosphate | Riboflavin 5'-Monophosphate | 5'-Monophosphate, Riboflavin | Riboflavin 5' Monophosphate | FMN | Riboflavin Mononucleotide | Mononucleotide, Riboflavin | Flavin Mononucleotide Sodium Salt | Sodium Riboflavin Phosphate | Phosphate, Sodium Riboflavin | Riboflavin Phosphate, Sodium | Flavin Mononucleotide Monosodium Salt, Dihydrate | Flavin Mononucleotide Disodium Salt | Flavin Mononucleotide Monosodium Salt
Chemical Information
Molecular Formula C17H21N4O9P
CAS Registry Number 26193-20-4
SMILES CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthenopia06.01.01.002--Not Available
Blepharitis23.03.04.012; 06.04.04.001--Not Available
Corneal epithelium defect06.06.03.012--Not Available
Corneal oedema06.04.02.001--Not Available
Corneal opacity06.06.03.005--Not Available
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dry eye06.08.02.001--
Eye discharge06.04.05.001--Not Available
Eye pain06.08.03.002--
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.004--Not Available
Halo vision06.02.06.003--Not Available
Headache17.14.01.001--
Keratitis06.04.02.002--
Lacrimation increased06.08.02.004--
Ocular hyperaemia06.04.05.004--Not Available
Photophobia17.17.02.006; 06.01.01.004--
Punctate keratitis06.04.02.003--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Visual acuity reduced06.02.10.012; 17.17.01.011--
Visual impairment06.02.10.013--Not Available
Vitreous detachment06.09.01.002; 12.01.04.005--Not Available
Foreign body sensation in eyes06.01.01.006--Not Available
Corneal striae06.06.03.011--Not Available
Anterior chamber flare06.04.10.003--Not Available
Glare06.02.06.013--Not Available
Eye oedema06.08.03.013--Not Available
Eye pruritus06.04.05.006--Not Available
Ocular discomfort06.08.03.008--Not Available
Anterior chamber cell06.04.10.001--Not Available
Corneal thinning06.06.03.009--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages